{
  "id": 235388,
  "title": "Alkeus, an unorthodox eye drug startup, acquired by Tarsus for up to $800M",
  "url": "https://urgent.news/2026/08/06/alkeus-an-unorthodox-eye-drug-startup-acquired-by-tarsus-for-up-to",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-06T18:07:00.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/alkeus-tarsus-acquire-stargardt-drug-startup-boger/827243/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Alkeus brought to late-stage testing a Stargardt disease therapy that former executive chairman and Vertex founder Josh Boger once called, “if it works, the most perfect drug I’ve ever seen.”",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Endpoints News",
        "title": "Tarsus bets $450M on Alkeus’ Stargardt drug",
        "url": "https://urgent.news/2026/08/06/tarsus-bets-450m-on-alkeus-stargardt-drug",
        "published": "2026-08-06T12:57:19.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}